PHYLLOCONTIN Drug Patent Profile
✉ Email this page to a colleague
When do Phyllocontin patents expire, and what generic alternatives are available?
Phyllocontin is a drug marketed by Pharm Res Assoc and is included in one NDA.
The generic ingredient in PHYLLOCONTIN is aminophylline. There are four drug master file entries for this compound. Four suppliers are listed for this compound. Additional details are available on the aminophylline profile page.
DrugPatentWatch® Litigation and Generic Entry Outlook for Phyllocontin
A generic version of PHYLLOCONTIN was approved as aminophylline by HOSPIRA on October 26th, 1983.
AI Research Assistant
Questions you can ask:
- What is the 5 year forecast for PHYLLOCONTIN?
- What are the global sales for PHYLLOCONTIN?
- What is Average Wholesale Price for PHYLLOCONTIN?
Summary for PHYLLOCONTIN
US Patents: | 0 |
Applicants: | 1 |
NDAs: | 1 |
Raw Ingredient (Bulk) Api Vendors: | 81 |
Clinical Trials: | 1 |
Patent Applications: | 3,848 |
Formulation / Manufacturing: | see details |
DailyMed Link: | PHYLLOCONTIN at DailyMed |
![PHYLLOCONTIN drug patent expirations Drug patent expirations by year for PHYLLOCONTIN](/p/graph/s/t/PHYLLOCONTIN-patent-expirations.png)
Recent Clinical Trials for PHYLLOCONTIN
Identify potential brand extensions & 505(b)(2) entrants
Sponsor | Phase |
---|---|
Action Medical Research | Phase 1 |
St Stephens Aids Trust | Phase 1 |
US Patents and Regulatory Information for PHYLLOCONTIN
Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Pharm Res Assoc | PHYLLOCONTIN | aminophylline | TABLET, EXTENDED RELEASE;ORAL | 086760-001 | Approved Prior to Jan 1, 1982 | DISCN | No | No | ⤷ Sign Up | ⤷ Sign Up | ⤷ Sign Up | ||||
>Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |